EP3989972
Glúkagon-líkir peptíð-1-viðtaka-örvar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
19.6.2020EP published:
8.11.2023EP application number:
20739523.7
EP translation filed:
11.12.2023Grant published:
15.1.2024EPO information:
European Patent Register
Max expiry date:
18.6.2040Expiry date:
18.6.2026Next due date:
30.6.2026
Title in English:
GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTSLanguage of the patent:
English
Timeline
Today
19.6.2020EP application
8.11.2023EP Publication
11.12.2023Translation submitted
15.1.2024Registration published
18.6.2026Expires
Owner
Name:
ELI LILLY AND COMPANYAddress:
Lilly Corporate Center, Indianapolis, IN 46206-6288, US
Inventor
Name:
COATES, David AndrewAddress:
Indianapolis, Indiana 46206-6288, US
Name:
FIELDS, ToddAddress:
Indianapolis, Indiana 46206-6288, US
Name:
HO, Joseph DanielAddress:
Indianapolis, Indiana 46206-6288, US
Name:
QU, FuchengAddress:
Indianapolis, Indiana 46206-6288, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201962868117 PDate:
28.6.2019Country:
US
Number:
201962904906 PDate:
24.9.2019Country:
US
Classification
Categories:
A61K 31/4439, C07D 405/14, A61P 3/10
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 23.5.2024
Expires: 18.6.2025
Payer: Árnason Faktor ehf.
Number: 6
Paid: 12.6.2025
Expires: 18.6.2026
Payer: Árnason Faktor ehf.